INDV

Indivior Pharmaceuticals Inc. Common Stock (INDV)

Stock · NASDAQ · Health Care

$34.87as of 8/28/2026

Price chart

Open in TradingView

Active signals

200 SMA Touch90.1%Support Reject31.4%BOLL Breakdown16.7%
Resistance level
$37.84
Industry
Biotechnology: Pharmaceutical Preparations

About INDV

Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
827

Fundamentals

1-day range
$38.73$40
Market cap
$4.82B
P/E (trailing)
12.77
P/E (forward)
7.99
EPS (trailing)
$2.78
Dividend yield
—
Beta
0.56
Avg. volume
2.01M
Ex-dividend date
June 16, 2016
52-week range
$22.22$42.81
Next earnings: November 5, 2026 · EPS estimate $1.12confirmed

How Indivior Pharmaceuticals Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$1.24BNet Income$210.00M (17%)SG&A$634.00M (51%)Cost of Revenue$246.00M (20%)Other$120.00M (10%)Tax$29.00M (2%)INDV

Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub

Forecasts

4 analyst ratings

Buy 92%
Hold 8%
Sell 0%
1-year price forecast
High
$53
+52.0%
Median
$50
+43.4%
Low
$43
+23.3%

Indivior Pharmaceuticals Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • INDV
    Indivior Pharmaceuticals Inc. Common Stock
    $34.87
    ▼ 1.22%
    Market cap $4.82BP/E 12.77
    $22.22$42.81
  • ACAD
    ACADIA Pharmaceuticals Inc. Common Stock
    $29.13
    ▼ 2.02%
    Market cap $4.87BP/E 12.85
    $19.69$30.96
  • MANE
    Veradermics Incorporated Common Stock
    $97.53
    ▼ 4.20%
    Market cap $4.54BP/E —
    $32$131.24
  • GRFS
    Grifols S.A. American Depositary Shares
    $7.68
    ▼ 1.79%
    Market cap $5.38BP/E 13.31
    $8.43$12.87
  • MIRM
    Mirum Pharmaceuticals Inc. Common Stock
    $97.44
    ▼ 2.32%
    Market cap $5.74BP/E —
    $63.23$130
  • VKTX
    Viking Therapeutics Inc. Common Stock
    $32.15
    ▼ 5.05%
    Market cap $3.88BP/E —
    $22.96$43.15
  • GPCR
    Structure Therapeutics Inc. American Depositary Shares
    $47.38
    ▼ 3.74%
    Market cap $3.74BP/E —
    $18.26$94.9

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
1.45M
Disposed
685.7K
  • Woodrow D. Anderson · August 27, 2026 · Buy
    1.5K @ $35.69
  • Mark Stejbach · August 10, 2026 · ?
    36.0K @ $1.62
  • Woodrow D. Anderson · August 5, 2026 · Buy
    1.5K @ $36.28
  • Christian Heidbreder · July 10, 2026 · Sale
    18.6K @ $41.14
  • Joseph Ciaffoni · June 22, 2026 · Option Exercise
    1.27M
  • Joseph Ciaffoni · June 22, 2026 · Tax Withholding
    612.5K @ $38.32
  • Christian Heidbreder · June 11, 2026 · Sale
    18.6K @ $38.06
  • Timothy Thompson · June 11, 2026 · ?
    3.9K @ $13.88
  • Juliet Thompson · June 11, 2026 · ?
    1.9K @ $13.88
  • Timothy Thompson · June 11, 2026 · ?
    1.9K @ $13.88
  • Ryan Preblick · June 8, 2026 · Sale
    36.0K @ $37.7
  • Shaun Thaxter · May 14, 2026 · ?
    100.0K @ $0.446414
  • Tatjana May · May 14, 2026 · ?
    22.3K @ $0.445785
  • David E. Wheadon · May 13, 2026 · Grant
    10.4K
  • Stuart A. Kingsley · May 13, 2026 · Grant
    6.5K

Institutional Ownership

March 31, 2026

Total shares held
118.33M
Total value held
$3.50B
Institutional holders
283
Top holders this quarter
  • Unknown18.54M
  • Unknown6.98M
  • Unknown5.59M
  • Unknown4.90M
  • Unknown4.75M
  • Unknown4.60M
  • Unknown4.53M
  • Unknown4.32M
  • Unknown3.71M
  • Unknown3.51M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.